Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine

R. C. Prielipp, G. P. Zaloga, J. F. Butterworth IV, P. G. Robertie, L. M. Dudas, K. W. Black, R. L. Royster

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Intravenous magnesium supplementation is often used to control cardiac arrhythmias and coronary artery vasospasm resulting from disturbances of magnesium homeostasis after coronary artery bypass surgery. Many such patients also require inotropic drug support of depressed myocardial function. However, increased serum magnesium concentrations directly depress cardiac contractility in animals and may interfere with catecholamine actions. To determine whether small intravenous doses of magnesium sulfate (MgSO4) interfere with the cardiotonic actions of epinephrine, we examined the hemodynamic effects of MgSO4 and epinephrine infusion in 17 cardiac surgical patients on their 1st postoperative day in a prospective, controlled study. In 11 patients, infusion of MgSO4 (7-mg·kg-1 bolus followed by 10 mg·kg-1·h-1 as a continuous infusion) increased serum magnesium concentrations by 44% (mean ± standard error of the mean [SEM] of 0.8 ± 0.1 to 1.2 ± 0.1 mM; P < 0.01) but had no significant effect on heart rate; mean arterial, central venous, or pulmonary arterial occlusion pressures; or cardiac output. Epinephrine infusion (30 ng·kg-1·min-1) significantly increased cardiac index (2.7 ± 0.1 to 3.1 ± 0.21·min-1·m-2; P < 0.05); this effect was not altered by MgSO4 administration (n = 11). However, MgSO4 significantly blunted epinephrine's hypertensive action and prevented a significant increase in mean arterial pressure during concurrent MgSO4-epinephrine administration. Six placebo control patients were given two sequential infusions of epinephrine separated by a placebo infusion to rule out an effect of time on the hemodynamic response to epinephrine. Mean arterial pressure and cardiac index responses to epinephrine were identical before and after placebo infusion. We conclude that infusion of the small doses of MgSO4 after coronary surgery to treat arrhythmias and vasospasm attenuates the vasoconstrictor actions of epinephrine but has no effect on epinephrine's cardiotonic activity.

Original languageEnglish (US)
Pages (from-to)973-979
Number of pages7
JournalAnesthesiology
Volume74
Issue number6
DOIs
StatePublished - Jan 1 1991

Fingerprint

Cardiotonic Agents
Magnesium
Epinephrine
Arterial Pressure
Placebos
Cardiac Arrhythmias
Hemodynamics
Coronary Vasospasm
Magnesium Sulfate
Vasoconstrictor Agents
Serum
Coronary Artery Bypass
Cardiac Output
Catecholamines
Homeostasis
Heart Rate
Prospective Studies

Keywords

  • Cardiac
  • Catecholamines
  • Epinephrine
  • Ions
  • Magnesium
  • Surgery
  • Sympathetic nervous system

Cite this

Prielipp, R. C., Zaloga, G. P., Butterworth IV, J. F., Robertie, P. G., Dudas, L. M., Black, K. W., & Royster, R. L. (1991). Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine. Anesthesiology, 74(6), 973-979. https://doi.org/10.1097/00000542-199106000-00002

Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine. / Prielipp, R. C.; Zaloga, G. P.; Butterworth IV, J. F.; Robertie, P. G.; Dudas, L. M.; Black, K. W.; Royster, R. L.

In: Anesthesiology, Vol. 74, No. 6, 01.01.1991, p. 973-979.

Research output: Contribution to journalArticle

Prielipp, RC, Zaloga, GP, Butterworth IV, JF, Robertie, PG, Dudas, LM, Black, KW & Royster, RL 1991, 'Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine', Anesthesiology, vol. 74, no. 6, pp. 973-979. https://doi.org/10.1097/00000542-199106000-00002
Prielipp, R. C. ; Zaloga, G. P. ; Butterworth IV, J. F. ; Robertie, P. G. ; Dudas, L. M. ; Black, K. W. ; Royster, R. L. / Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine. In: Anesthesiology. 1991 ; Vol. 74, No. 6. pp. 973-979.
@article{f3b900f559f7409e9b271c0240ce6674,
title = "Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine",
abstract = "Intravenous magnesium supplementation is often used to control cardiac arrhythmias and coronary artery vasospasm resulting from disturbances of magnesium homeostasis after coronary artery bypass surgery. Many such patients also require inotropic drug support of depressed myocardial function. However, increased serum magnesium concentrations directly depress cardiac contractility in animals and may interfere with catecholamine actions. To determine whether small intravenous doses of magnesium sulfate (MgSO4) interfere with the cardiotonic actions of epinephrine, we examined the hemodynamic effects of MgSO4 and epinephrine infusion in 17 cardiac surgical patients on their 1st postoperative day in a prospective, controlled study. In 11 patients, infusion of MgSO4 (7-mg·kg-1 bolus followed by 10 mg·kg-1·h-1 as a continuous infusion) increased serum magnesium concentrations by 44{\%} (mean ± standard error of the mean [SEM] of 0.8 ± 0.1 to 1.2 ± 0.1 mM; P < 0.01) but had no significant effect on heart rate; mean arterial, central venous, or pulmonary arterial occlusion pressures; or cardiac output. Epinephrine infusion (30 ng·kg-1·min-1) significantly increased cardiac index (2.7 ± 0.1 to 3.1 ± 0.21·min-1·m-2; P < 0.05); this effect was not altered by MgSO4 administration (n = 11). However, MgSO4 significantly blunted epinephrine's hypertensive action and prevented a significant increase in mean arterial pressure during concurrent MgSO4-epinephrine administration. Six placebo control patients were given two sequential infusions of epinephrine separated by a placebo infusion to rule out an effect of time on the hemodynamic response to epinephrine. Mean arterial pressure and cardiac index responses to epinephrine were identical before and after placebo infusion. We conclude that infusion of the small doses of MgSO4 after coronary surgery to treat arrhythmias and vasospasm attenuates the vasoconstrictor actions of epinephrine but has no effect on epinephrine's cardiotonic activity.",
keywords = "Cardiac, Catecholamines, Epinephrine, Ions, Magnesium, Surgery, Sympathetic nervous system",
author = "Prielipp, {R. C.} and Zaloga, {G. P.} and {Butterworth IV}, {J. F.} and Robertie, {P. G.} and Dudas, {L. M.} and Black, {K. W.} and Royster, {R. L.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1097/00000542-199106000-00002",
language = "English (US)",
volume = "74",
pages = "973--979",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Magnesium inhibits the hypertensive but not the cardiotonic actions of low-dose epinephrine

AU - Prielipp, R. C.

AU - Zaloga, G. P.

AU - Butterworth IV, J. F.

AU - Robertie, P. G.

AU - Dudas, L. M.

AU - Black, K. W.

AU - Royster, R. L.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Intravenous magnesium supplementation is often used to control cardiac arrhythmias and coronary artery vasospasm resulting from disturbances of magnesium homeostasis after coronary artery bypass surgery. Many such patients also require inotropic drug support of depressed myocardial function. However, increased serum magnesium concentrations directly depress cardiac contractility in animals and may interfere with catecholamine actions. To determine whether small intravenous doses of magnesium sulfate (MgSO4) interfere with the cardiotonic actions of epinephrine, we examined the hemodynamic effects of MgSO4 and epinephrine infusion in 17 cardiac surgical patients on their 1st postoperative day in a prospective, controlled study. In 11 patients, infusion of MgSO4 (7-mg·kg-1 bolus followed by 10 mg·kg-1·h-1 as a continuous infusion) increased serum magnesium concentrations by 44% (mean ± standard error of the mean [SEM] of 0.8 ± 0.1 to 1.2 ± 0.1 mM; P < 0.01) but had no significant effect on heart rate; mean arterial, central venous, or pulmonary arterial occlusion pressures; or cardiac output. Epinephrine infusion (30 ng·kg-1·min-1) significantly increased cardiac index (2.7 ± 0.1 to 3.1 ± 0.21·min-1·m-2; P < 0.05); this effect was not altered by MgSO4 administration (n = 11). However, MgSO4 significantly blunted epinephrine's hypertensive action and prevented a significant increase in mean arterial pressure during concurrent MgSO4-epinephrine administration. Six placebo control patients were given two sequential infusions of epinephrine separated by a placebo infusion to rule out an effect of time on the hemodynamic response to epinephrine. Mean arterial pressure and cardiac index responses to epinephrine were identical before and after placebo infusion. We conclude that infusion of the small doses of MgSO4 after coronary surgery to treat arrhythmias and vasospasm attenuates the vasoconstrictor actions of epinephrine but has no effect on epinephrine's cardiotonic activity.

AB - Intravenous magnesium supplementation is often used to control cardiac arrhythmias and coronary artery vasospasm resulting from disturbances of magnesium homeostasis after coronary artery bypass surgery. Many such patients also require inotropic drug support of depressed myocardial function. However, increased serum magnesium concentrations directly depress cardiac contractility in animals and may interfere with catecholamine actions. To determine whether small intravenous doses of magnesium sulfate (MgSO4) interfere with the cardiotonic actions of epinephrine, we examined the hemodynamic effects of MgSO4 and epinephrine infusion in 17 cardiac surgical patients on their 1st postoperative day in a prospective, controlled study. In 11 patients, infusion of MgSO4 (7-mg·kg-1 bolus followed by 10 mg·kg-1·h-1 as a continuous infusion) increased serum magnesium concentrations by 44% (mean ± standard error of the mean [SEM] of 0.8 ± 0.1 to 1.2 ± 0.1 mM; P < 0.01) but had no significant effect on heart rate; mean arterial, central venous, or pulmonary arterial occlusion pressures; or cardiac output. Epinephrine infusion (30 ng·kg-1·min-1) significantly increased cardiac index (2.7 ± 0.1 to 3.1 ± 0.21·min-1·m-2; P < 0.05); this effect was not altered by MgSO4 administration (n = 11). However, MgSO4 significantly blunted epinephrine's hypertensive action and prevented a significant increase in mean arterial pressure during concurrent MgSO4-epinephrine administration. Six placebo control patients were given two sequential infusions of epinephrine separated by a placebo infusion to rule out an effect of time on the hemodynamic response to epinephrine. Mean arterial pressure and cardiac index responses to epinephrine were identical before and after placebo infusion. We conclude that infusion of the small doses of MgSO4 after coronary surgery to treat arrhythmias and vasospasm attenuates the vasoconstrictor actions of epinephrine but has no effect on epinephrine's cardiotonic activity.

KW - Cardiac

KW - Catecholamines

KW - Epinephrine

KW - Ions

KW - Magnesium

KW - Surgery

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0025766670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025766670&partnerID=8YFLogxK

U2 - 10.1097/00000542-199106000-00002

DO - 10.1097/00000542-199106000-00002

M3 - Article

C2 - 2042788

AN - SCOPUS:0025766670

VL - 74

SP - 973

EP - 979

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 6

ER -